Kelly Lawler, DPM
Podiatrist · Irving, TXNPI 1417068909
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Medline Industries LP at 54.0% of the total. 2025 is the largest year on record at $161, 3.5 times the $46 reported in 2019. That places this record below the midpoint for podiatrist clinicians in TX, where the typical reported total is $1,991.
Across 9 payments — averaging $33.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medline Industries LP$161
- Stryker$50
- Smith+Nephew$23
- Organogenesis Inc.$23
- Acell, Inc.$18
- Musculoskeletal Transplant Foundation Inc.$12
- plus $10 from 2 others
What the payments were for
- Food & beverage$298100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medline Industries LP | 1 | $161 |
| Stryker(2 entities) | 2 | $50 |
| Smith+Nephew | 1 | $23 |
| Organogenesis Inc. | 1 | $23 |
| Acell, Inc. | 1 | $18 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $5 |
| Orthofix Medical, Inc. | 1 | $5 |
How this compares
$298 in reported general payments places this provider in the 15th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 96 | $1,335 |
| Ketoconazole | 35 | $1,160 |
| Ciclopirox | 50 | $1,063 |
| Terbinafine Hcl | 38 | $349 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $198 |
| Mupirocin | 12 | $102 |
| Meloxicam | 14 | $47 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Irving
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
- Richard AdamsGranbury$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.